1. Home
  2. LARK vs SGMT Comparison

LARK vs SGMT Comparison

Compare LARK & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • SGMT
  • Stock Information
  • Founded
  • LARK 1885
  • SGMT 2006
  • Country
  • LARK United States
  • SGMT United States
  • Employees
  • LARK N/A
  • SGMT N/A
  • Industry
  • LARK Major Banks
  • SGMT
  • Sector
  • LARK Finance
  • SGMT
  • Exchange
  • LARK Nasdaq
  • SGMT Nasdaq
  • Market Cap
  • LARK 140.8M
  • SGMT 159.0M
  • IPO Year
  • LARK N/A
  • SGMT 2023
  • Fundamental
  • Price
  • LARK $24.00
  • SGMT $4.39
  • Analyst Decision
  • LARK
  • SGMT Buy
  • Analyst Count
  • LARK 0
  • SGMT 6
  • Target Price
  • LARK N/A
  • SGMT $23.00
  • AVG Volume (30 Days)
  • LARK 4.4K
  • SGMT 1.2M
  • Earning Date
  • LARK 01-29-2025
  • SGMT 11-13-2024
  • Dividend Yield
  • LARK 3.33%
  • SGMT N/A
  • EPS Growth
  • LARK 14.37
  • SGMT N/A
  • EPS
  • LARK 2.14
  • SGMT N/A
  • Revenue
  • LARK $56,988,000.00
  • SGMT N/A
  • Revenue This Year
  • LARK N/A
  • SGMT N/A
  • Revenue Next Year
  • LARK N/A
  • SGMT N/A
  • P/E Ratio
  • LARK $11.20
  • SGMT N/A
  • Revenue Growth
  • LARK N/A
  • SGMT N/A
  • 52 Week Low
  • LARK $17.05
  • SGMT $2.39
  • 52 Week High
  • LARK $25.25
  • SGMT $20.71
  • Technical
  • Relative Strength Index (RSI)
  • LARK 54.59
  • SGMT 44.30
  • Support Level
  • LARK $23.05
  • SGMT $4.06
  • Resistance Level
  • LARK $24.49
  • SGMT $7.38
  • Average True Range (ATR)
  • LARK 0.58
  • SGMT 0.63
  • MACD
  • LARK -0.06
  • SGMT -0.11
  • Stochastic Oscillator
  • LARK 75.68
  • SGMT 9.94

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four-family residential real estate, construction and land, commercial real estate, commercial, agriculture, municipal and consumer loans. In addition, it also invests in certain investment and mortgage related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

Share on Social Networks: